Genelux (GNLX) Total Liabilities (2022 - 2026)
Genelux (GNLX) recorded quarterly Total Liabilities of $9.5 million in Q1 2026, up 26.3% quarter-over-quarter from $7.5 million in Q4 2025, and up 131.67% on a YoY basis from $4.1 million in Q1 2025.
Genelux (GNLX) Total Liabilities (2022 - 2026) Analysis & Trends
Genelux's Total Liabilities history runs 5 years deep, the most recent figure standing at $9.5 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 131.67% year-over-year to $9.5 million; the TTM figure through Mar 2026 stood at $9.5 million (up 131.67% YoY), while the FY2025 annual figure was $7.5 million, down 11.36% from the prior year.
- Total Liabilities was $9.5 million for Q1 2026 at Genelux, up from $7.5 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $41.3 million in Q4 2022 to a low of -$29.8 million in Q1 2025.
- Historically, Total Liabilities has averaged $6.8 million across 5 years, with a median of $8.3 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities soared 456.45% in 2024, then sank 411.16% in 2025.
- A 5-year view of Total Liabilities shows it stood at $41.3 million in 2022, then tumbled by 79.62% to $8.4 million in 2023, then advanced by 0.26% to $8.4 million in 2024, then decreased by 11.36% to $7.5 million in 2025, then climbed by 26.3% to $9.5 million in 2026.
- The last three Total Liabilities figures came in at $9.5 million (Q1 2026), $7.5 million (Q4 2025), and $6.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 9.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.45 Mn |
| Dec 31, 2025 | 7.48 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | 8.35 Mn |
| Mar 31, 2025 | -29.85 Mn |
| Dec 31, 2024 | 8.44 Mn |
| Sep 30, 2024 | 7.18 Mn |
| Jun 30, 2024 | 7.51 Mn |
| Mar 31, 2024 | 9.59 Mn |
| Dec 31, 2023 | 8.42 Mn |
| Sep 30, 2023 | 10.04 Mn |
| Jun 30, 2023 | -22.26 Mn |
| Mar 31, 2023 | -2.69 Mn |
| Dec 31, 2022 | 41.31 Mn |
| Sep 30, 2022 | 32.33 Mn |